REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 45 filers reported holding REPROS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
Renaissance Technologies | 716,413 | $946,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |